Viewing nowCombinationGlicitamet XR Extended-release Tablet 100/1000 Milligrams
Sitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 202201954 · Approved 2022.05.11 · Insurance code 657308740
Improvement of glycemic control in patients with type 2 diabetes
This drug helps patients with type 2 diabetes control their blood sugar levels when used along with diet and exercise therapy. Sitagliptin and metformin work together to effectively lower blood sugar levels and improve glycemic control. Therefore, it is used in the treatment of type 2 diabetes in conjunction with dietary therapy and exercise.
In antidiabetic therapy, the dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: sitagliptin 100 mg and metformin 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin, take this medicine with a meal once daily, preferably in the evening, and increase the dose gradually. Take one 100/1000 mg extended-release tablet once daily. Patients taking the 50/500 mg extended-release tablet or the 50/1000 mg extended-release tablet should take 2 tablets together once daily. 1. Patients not currently receiving metformin: For patients with no prior antidiabetic drug treatment whose blood glucose cannot be adequately controlled with monotherapy, or whose blood glucose cannot be adequately controlled with sitagliptin monotherapy, the initial total daily dose of this medicine is sitagliptin 100 mg and metformin 1000 mg. If adequate glycemic control cannot be achieved with the initial dose, the dose may be increased gradually up to the maximum recommended daily dose of metformin, 2000 mg, to reduce gastrointestinal adverse reactions caused by metformin. Patients with renal impairment who are receiving a reduced dose of sitagliptin should not be switched to this medicine. 2. Patients receiving metformin: - The recommended initial total daily dose of this medicine for patients whose blood glucose cannot be adequately controlled with metformin monotherapy is sitagliptin 100 mg and the patient's current metformin dose. - Patients switching from combination therapy with sitagliptin and metformin to this medicine may start at their current doses of sitagliptin and metformin. - Patients taking immediate-release metformin at a current dose of 850 mg or 1000 mg twice daily may start this medicine at a dose of two 50/1000 mg extended-release tablets once daily. 3. Patients whose blood glucose cannot be adequately controlled with combination therapy of metformin and a sulfonylurea, metformin and insulin, or metformin and a thiazolidinedione: The initial total daily dose of this medicine is sitagliptin 100 mg, and the initial dose of metformin should be determined by taking the patient's blood glucose level and current dose into consideration. Increase the dose gradually to reduce gastrointestinal adverse reactions caused by metformin. When this medicine is coadministered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia caused by the sulfonylurea or insulin. Patients with renal impairment This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] ≥ 45 and < 60 mL/min or estimated glomerular filtration rate [eGFR] ≥ 45 and < 60 mL/min/1.73m2), who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. Because the starting dose of metformin is 500 mg or 850 mg once daily, treatment should not be initiated with this medicine. The maximum recommended dose of metformin is 1000 mg daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 mL/min or eGFR < 45 mL/min/1.73m2, discontinue this medicine immediately.
This drug consists of sitagliptin and metformin, and is used in the treatment of diabetes. Firstly, this drug can cause serious hypersensitivity reactions, although rare, so if allergic symptoms or skin abnormalities occur within 3 months after administration, immediate discontinuation and consultation with a physician are required. Additionally, pancreatitis, which is an inflammation of the pancreas, may occur, so if symptoms of pancreatitis such as abdominal pain, nausea, or vomiting appear, the use of this drug should be discontinued immediately and medical attention sought. The metformin contained in this drug may cause a rare complication called lactic acidosis, which can be dangerous due to excessive accumulation of lactic acid in the body, hence it should not be used in cases of severe dehydration, cardiovascular disease, liver disease, or acute infection. Patients with moderately compromised kidney function or with acute heart failure, acute myocardial infarction, or those undergoing iodine contrast imaging procedures should not be administered this drug, and it should be avoided in pregnant or breastfeeding women. While taking this medication, renal function should be monitored regularly to ensure there are no abnormalities, and especially for elderly patients or those with compromised renal function, caution is necessary. Since this medication lowers blood sugar, if meals are skipped or physical activity increases suddenly, hypoglycemia might occur, so attention to symptoms is necessary. When used with other hypoglycemic agents or insulin, the risk of hypoglycemia may increase, and dosage adjustments may be needed. Alcohol consumption can increase the risk of lactic acidosis, so excessive drinking should be avoided during the course of this medication. In case of surgery, this medication should be discontinued 48 hours prior to the procedure and can be resumed after oral intake and normal recovery of renal function post-surgery. Also, while taking this medication, it is recommended to regularly check blood tests and vitamin B12 levels to ensure there are no deficiencies. Lastly, safety and efficacy have not been established for children, and it is not recommended for individuals under 18 years of age. Adhering closely to these precautions will help this medication contribute to diabetes management.
anaphylaxis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Also, it is best to store it at room temperature between 1 and 30 degrees Celsius, avoiding extremely hot or cold places.
Bright blue, oval-shaped, both sides convex extended-release film-coated tablet
28 tablets/bottle, 56 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.